Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Schmidt

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Journal of Virology|January 13, 2017
Phyloepidemiological Analysis Reveals that Viral Divergence Led to the Paucity of Simian Immunodeficiency Virus SIVmus/gsn/mon Infections in Wild PopulationsFabian Schmidt, Florian Liegeois, Edward J D Greenwood, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunityFrauke Muecksch, Helen Wise, Kate Templeton, et al.
The Lancet. Microbe|May 31, 2022
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysisFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Science (New York, N.Y.)|June 21, 2014
HIV-1-induced AIDS in monkeysTheodora Hatziioannou, Gregory Q Del Prete, Brandon F Keele, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2023
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodiesTrinity Zang, Edmund Osei Kuffour, Viren A Baharani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of Virology|January 13, 2017
Phyloepidemiological Analysis Reveals that Viral Divergence Led to the Paucity of Simian Immunodeficiency Virus SIVmus/gsn/mon Infections in Wild PopulationsFabian Schmidt, Florian Liegeois, Edward J D Greenwood, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunityFrauke Muecksch, Helen Wise, Kate Templeton, et al.
The Lancet. Microbe|May 31, 2022
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysisFrauke Muecksch, Helen Wise, Kate Templeton, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Science (New York, N.Y.)|June 21, 2014
HIV-1-induced AIDS in monkeysTheodora Hatziioannou, Gregory Q Del Prete, Brandon F Keele, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2023
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodiesTrinity Zang, Edmund Osei Kuffour, Viren A Baharani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 PatientsLarry L Luchsinger, Brett Ransegnola, Daniel Jin, et al.
Nature Communications|July 8, 2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodiesAllison J Greaney, Tyler N Starr, Christopher O Barnes, et al.
Pageof 11